Two purified isozymes of protein carboxyl methyltransferase from bovine brain catalyze the substoichiometric transfer of methyl groups in vitro from S-adenosyl-L-[methyl-3H]methionine to several erythrocyte membrane proteins, which include bands 2.1, 3, and 4.1, as well as several integral membrane polypeptides. D-Aspartic acid f3-[3H]methyl ester has been isolated from proteolytic digests of these methylated proteins, suggesting that protein D-aspartyl residues can serve as methyl-acceptor sites for the two brain enzymes. This formation of D-aspartic acid 3-[3H]methyl ester is competitively inhibited by the peptide L-Val-L-Tyr-L-Pro-LisoAsp-Gly-L-Ala, which contains an L-aspartyl residue in an unusual /-peptide linkage. Since this peptide is a stoichiometric substrate for the brain methyltransferases, it appears that one enzymatic activity can catalyze methyl ester formation at both D-aspartyl and L-isoaspartyl sites. In these respects, the activity of both brain isozymes closely resembles those previously described for the erythrocyte enzyme. The results are discussed in terms of a model in which derivatized aspartyl residues in proteins, arising by either racemization or isomerization, are recognized by the methyltransferase; the enzyme may function in either the metabolism or correction of the altered structures. The presence of a similar enzyme in both translationally active (brain) and inactive (erythrocyte) tissues suggests that the reactions are of general importance to cellular integrity.
[3H]methyl ester has been isolated from proteolytic digests of these methylated proteins, suggesting that protein D-aspartyl residues can serve as methyl-acceptor sites for the two brain enzymes. This formation of D-aspartic acid 3-[3H]methyl ester is competitively inhibited by the peptide L-Val-L-Tyr-L-Pro-LisoAsp-Gly-L-Ala, which contains an L-aspartyl residue in an unusual /-peptide linkage. Since this peptide is a stoichiometric substrate for the brain methyltransferases, it appears that one enzymatic activity can catalyze methyl ester formation at both D-aspartyl and L-isoaspartyl sites. In these respects, the activity of both brain isozymes closely resembles those previously described for the erythrocyte enzyme. The results are discussed in terms of a model in which derivatized aspartyl residues in proteins, arising by either racemization or isomerization, are recognized by the methyltransferase; the enzyme may function in either the metabolism or correction of the altered structures. The presence of a similar enzyme in both translationally active (brain) and inactive (erythrocyte) tissues suggests that the reactions are of general importance to cellular integrity.
Protein carboxyl methyltransferases are widely distributed in both bacteria and eukaryotic tissues (1) . In bacteria, very specific carboxyl methyltransferases regulate the bacterial chemotactic response by the methylation of several glutamyl residues in membrane chemoreceptor proteins (2, 3) . The eukaryotic enzymes, on the other hand, have very different characteristics. In vitro, these enzymes methylate a large variety of both heterologous and endogenous proteins in a substoichiometric fashion (1, (4) (5) (6) . The "nonspecific" methyltransferase is widely distributed in mammalian tissues (1) and has been purified from both mammalian brain (1, (5) (6) (7) and erythrocyte (8, 9) tissues. In brain, there are at least two functionally similar isozymes that can be separated by DEAE-cellulose chromatography (5) .
The precise function of eukaryotic protein carboxyl methylation reactions has not been determined. It has been proposed that the brain enzyme regulates several cellular processes, including, among others, the storage and release of neuroendocrine substances (10, 11) , the modulation of receptor function (12, 13) , and the regulation of calmodulin activity (14, 15) . However, the data supporting such roles have not been compelling (4, 16, 17) . In particular, the broad substrate specificity and substoichiometric nature of the reactions catalyzed by the enzyme are unusual features for regulatory post-translational modifications. Alternative roles for eukaryotic methylation reactions in the repair or metabolism of damaged proteins have recently been proposed. Evidence has been presented, which suggests that the substoichiometry of the reactions catalyzed by the eukaryotic methyltransferase is only an apparent one, reflecting the infrequent occurrence of derivatized protein aspartyl residues, which serve as the substrate sites for the enzyme (4, (18) (19) (20) .
The erythrocyte enzyme methylates several integral and peripheral membrane proteins both in vivo and in vitro (21, 22) . At least some of the membrane methyl acceptor sites are probably racemized aspartyl residues, because D-aspartic
has been isolated from proteolytic digests of the modified membrane proteins (18, 21) . Accordingly, the erythrocyte enzyme has been referred to as a protein D-aspartyl methyltransferase (4), although this must be taken as a tentative identification until sequences known to contain D-aspartyl residues can be shown to act as stoichiometric substrates for the enzyme.
A similar D-aspartyl methyltransferase activity has not been identified previously in brain, although it has recently been shown that the brain enzymes can recognize a second form of structurally altered aspartyl residues (19, 20) . In vitro, both brain isozymes catalyze the stoichiometric modification of an unusual L-isoaspartyl-containing form of adrenocorticotropin hormone, which has arisen by a deamidationlinked isomerization of the native hormone (19) . A synthetic peptide L-Val-L-Tyr-L-Pro-L-isoAsp-Gly-L-Ala can likewise be methylated stoichiometrically by either of the brain enzymes or by an activity present in erythrocyte cytosol (20) .
In this paper, we have addressed the question of whether the previously described erythrocyte protein D-aspartyl methyltransferase and the brain L-isoaspartyl methyltransferase represent the same enzymatic activity. Using erythrocyte membranes as the substrate for S-adenosyl-L-methionine (AdoMet)-dependent methylation in vitro, we show that the brain and erythrocyte enzymes appear to possess a common substrate specificity and that a single enzymatic activity apparently recognizes both D-aspartyl and L-isoaspartyl sequences.
MATERIALS AND METHODS Materials. AdoMet (iodide salt) was purchased from Sig- (15 Ci/mmol; 67 ,uM; 1 Ci = 37 GBq) was purchased from Amer- tTo whom reprint requests should be addressed.
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Preparation of Enzymes. Protein carboxyl methyltransferases I and II were purified from bovine brain to >90% and >75% homogeneity, respectively, as described (5 (23) .
Methylation of Erythrocyte Membranes by the Purified Methyltransferases. Hypomethylated membranes were prepared from erythrocytes that had been incubated for 20 hr in the presence of 5 mM adenosine and 5 mM L-homocysteine thiolactone as described (21, 24) .
RESULTS
Purified Brain Methyltransferases Catalyze the Methylation of Human Erythrocyte Membrane Proteins. We have previously shown that the erythrocyte methyltransferase in vitro recognizes several integral and peripheral polypeptides associated with hypomethylated erythrocyte membranes (21) . Fig. 1 shows the kinetics of methyl ester formation on hypomethylated erythrocyte membranes by the purified brain isozymes and the partially purified erythrocyte enzyme. For comparison, Fig. 1 The number of methyl esters formed per mg of membrane protein by the partially purified erythrocyte enzyme during the incubation period is similar to the value reported earlier for the affinity-purified erythrocyte enzyme. Under these conditions, the methylation of all membrane polypeptides is substoichiometric; the available methylation sites appear to be nearly saturated at <0.01 mol of methyl ester per mol of methyl-accepting polypeptide (21) .
Brain and Erythrocyte Enzymes Methylate the Same Erythrocyte Membrane Polypeptides. The polypeptides serving as methyl-accepting substrates for the three enzyme preparations were identified after separation by NaDodSO4/PAGE, pH 2.4, conditions designed to minimize the loss of protein methyl esters by chemical hydrolysis (25, 26) . In the absence of added enzyme, there is no detectable production of protein methyl esters (Fig. 2, lane a) II, or 870 ng of the 520-fold purified erythrocyte enzyme. After various times of incubation, the reactions were terminated by the addition of 1 ml of 10%o trichloroacetic acid at 0°C. Protein methyl esters were quantitated as acid-precipitable radioactivity, which was converted by base treatment to a volatile species-i.e., methanol, which could be extracted into toluene and isoamyl alcohol (21) .
as previously reported (21) , methylates a group of integral membrane proteins represented by band 3 and polypeptides with molecular weights of 45,000 and 28,000, the peripheral spectrin-binding proteins, bands 2.1 and 4.1, as well as other polypeptides at low levels (lane b). The brain protein carboxyl methyltransferase isozymes I (lane c) and II (lane d) each recognize the same set of polypeptides as the erythrocyte enzyme (Table 1 ). In addition, there are no differences in the hydrolytic stabilities of the methyl esters formed by either of the brain enzymes or the erythrocyte enzyme when measured at pH 8.9 and pH 10.0 (data not shown). However, there is a quantitative difference in substrate preference between the two brain enzymes, which is most apparent in the relative activities of the enzymes with the physiological acceptors, bands 2.1 and 4.1 (22) , as substrates ( Table 1 ). The fraction of the total radioactivity associated with these proteins is significantly greater when methyltransferase II, rather than methyltransferase I, is used as the catalyst.
L and the various brain and erythrocyte methyltransferase preparations for 60 min as described in Fig. 1 . At the end of the incubation, membranes were resuspended in 4 ml of sodium citrate buffer (0.2 M in Na+, pH 6.0) and pelleted by centrifugation for 10 min at 35,000 x g. The pellets were solubilized in 50 pJ of NaDodSO4 sample buffer (21, 22) . Twenty-microliter aliquots of the solubilized membrane proteins were separated by NaDodSO4/PAGE, pH 2.4 (25, 26) tides by brain methyltransferase I (Fig. 2, lane (21) .
To test whether the brain isozymes also catalyzed the formation of D-Aspf3[3HJMe, we isolated Asp(3Me from similar digests of membrane proteins methylated by the brain methyltransferase I and we determined its stereoconfiguration by chromatographic separation of the diastereomeric L-Leu-DAspBMe and L-Leu-L-Asp3Me derivatives (Fig. 3) . As shown in Fig. 3 added to the reaction mixtures, and the Aspf3Me fraction was separated from the mixture chromatographically as described (21) . The diastereomeric dipeptides L-Leu-D-Asp/3Me and L-Leu-L-Asp,8Me were constructed by reacting the purified Asp/3Me-containing fractions with L-leucine N-carboxyanhydride, and the dipeptides were separated by cation exchange chromatography on an amino acid analyzer resin (18, 27, 28 Although these results clearly demonstrate the formation of D-Asp/3Me by the brain enzyme, the actual proportion of methylated sites on membranes in this configuration is unknown. We can calculate that the radioactivity recovered as D-Aspj3[3H]Me typically represents only 0.1% of the total radioactivity originally present in membrane protein methyl esters, but this represents a lower limit because the majority of the methyl esters are converted into [3H]methanol during the protease digestion. Because L-aspartic acid a-methyl esters can be formed on peptide substrates with these enzymes (19, 20) , one would expect that a fraction of the membrane esters may also be in a linkages. However, we have not detected any aspartic acid a-[3H]methyl ester in the enzymatic digestion products, and it is unclear that this free amino acid Altos, CA) C18-reversed-phase column (4.6 x 250 mm), which was eluted isocratically with 0.1 M potassium phosphate (pH 3.0) at a flow rate of 1 ml/min. The absorbance of the eluent was monitored at 214 nm (-). At the time indicated by the arrow, the full-scale absorbance setting was changed from 2.0 to 0.05 A214. The entire fraction (1.0 ml) was assayed for radioactivity (e) by liquid scintillation counting in ester would be liberated in a standard proteolytic digestion protocol (20) . We have also not detected any L-Asp/3Me or glutamic acid -methyl ester. The small amount of radioactivity that comigrates with the L-Leu-L-Asp,8Me standard in Fig. 3 is probably due to a radioactive contaminant in the [3H]AdoMet originally used to label membrane methyl esters, because it is present at similar concentrations in digests made from reaction mixtures either lacking the brain enzyme or containing an inhibitory concentration of S-adenosyl-Lhomocysteine and because it can be resolved from the dipeptide upon further chromatography as in Fig. 4 (data not  shown) . Table 2 . Inhibition of membrane protein methylation by Re- action mixtures (0.5 ml), buffered with 50 mM imidazole (pH 7.0), were incubated for 2 hr at 370C, at which time the reactions were terminated by dilution in 5 ml of ice-cold sodium citrate buffer (0.2 M in Na', pH 6.0). Membrane protein methyl esters were determined as described in Proc. NatL Acad Sci. USA 81 (1984) 0 Broln'MT-I i i the methyl-acceptor specificity of each of these enzymes (Table 1) .
Using the same in vitro system, we had previously shown that the erythrocyte enzyme catalyzes the formation of DAspp3H]Me, which can be recovered in low yield from carboxypeptidase Y digests of the methylated proteins (21) . In Figs. 3 and 4 , we have shown that both of the brain isozymes also catalyze the formation of the same product, DAsp, 3 [3H]Me. Previously, both isozymes had been shown to methylate a deamidated isopeptide form of adrenocorticotropin hormone (19) and a synthetic L-isoaspartyl hexapeptide (20) . From the combined data, we conclude that there is a common group of methyl-acceptors shared by the two brain isozymes and the erythrocyte enzyme.
The presence of D-Asp. 3 [3H]Me in proteolytic digests of 3H-methylated membranes strongly suggests that the brain isozymes recognize membrane protein D-aspartyl residues as substrates. The infrequent occurrence of these residues is, indeed, consistent with the large number of protein substrates and substoichiometric nature of the methylation reaction ( Fig. 1; Table 1 ). Since the majority of the radioactivity originally present in methyl esters is recovered as [3H]methanol, however, we cannot determine what fraction of the esters were originally associated with the (3-carboxyl groups of D-aspartyl or the a-carboxyl groups of L-isoaspartyl residues.
Although it is not clear yet if membrane proteins themselves are methylated at L-isoaspartyl residues (cf. ref. 20) , the results of Table 2 suggest that D-aspartyl and L-isoaspartyl sequences may compete for the catalytic site of the methyltransferase. We show here that the production of membrane protein D-Asp,3Me by the highly purified brain methyltransferase I is decreased when the synthetic isopeptide L-Val-L-Tyr-L-Pro-L-isoAsp-Gly-L-Ala is present in the methylation mixture. Coupled with previous data that demonstrate the broad substrate specificity of the enzyme (1, 5, 6) , these findings suggest that there may be a fair amount of flexibility in the structure surrounding the active site, which allows the enzyme to accommodate a very heterogeneous group of protein substrates.
This unusual specificity of the enzyme for atypical aspartyl residues suggests that the function of the enzyme is involved with the metabolism and/or correction of damaged proteins (4, 18) . The presence of the methyltransferase in tissues such as brain that, unlike erythrocytes, have an active translational machinery makes it unlikely that protein carboxyl methylation is functionally important only when damaged proteins cannot be replaced by newly synthesized copies of the protein.
Clarification of the precise function(s) of the reaction, however, will probably require the development of additional defined substrates whose metabolism by cellular constituents can be monitored directly.
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